Richard E Chaisson Selected Research

Richard E Chaisson Research Topics

Disease

80	Tuberculosis (Tuberculoses) 09/2022 - 04/2002
22	HIV Infections (HIV Infection) 10/2021 - 04/2003
15	Infections 01/2021 - 01/2002
11	Acquired Immunodeficiency Syndrome (AIDS) 01/2021 - 07/2002
10	Latent Tuberculosis 01/2019 - 07/2002
6	Pulmonary Tuberculosis 01/2021 - 08/2006
6	Coinfection 01/2015 - 08/2003
5	Disease Progression 11/2019 - 03/2003
5	Drug-Related Side Effects and Adverse Reactions 01/2016 - 03/2003
4	Hepatitis B 01/2014 - 11/2004
3	Multiple Organ Failure (MODS) 10/2007 - 12/2002
2	COVID-19 01/2022 - 01/2021
2	Multidrug-Resistant Tuberculosis (Drug-Resistant Tuberculosis) 01/2020 - 01/2018
2	Communicable Diseases (Infectious Diseases) 10/2016 - 10/2016
2	Liver Diseases (Liver Disease) 01/2015 - 01/2005
2	Tuberculous Pericarditis 12/2014 - 09/2014
2	Immune Reconstitution Inflammatory Syndrome 01/2012 - 04/2011
2	Anemia 11/2011 - 01/2008
2	Pneumocystis Pneumonia (Pneumocystis carinii Pneumonia) 05/2011 - 10/2007
2	Nausea 01/2008 - 08/2006
2	Hepatitis C 01/2005 - 01/2002
2	Hepatitis 11/2004 - 01/2002
1	Hypertension (High Blood Pressure) 01/2020
1	Infant Death 01/2018
1	Latent Infection 01/2018
1	Rheumatoid Arthritis 07/2012
1	Psoriatic Arthritis 07/2012
1	Ankylosing Spondylitis 07/2012
1	Reinfection 06/2011
1	Silicotuberculosis 05/2011
1	Malaria 07/2010
1	Overweight 06/2010
1	Viremia 12/2009
1	Chronic Hepatitis B 12/2008
1	Hypersensitivity (Allergy) 11/2008
1	Vomiting 01/2008
1	Peripheral Nervous System Diseases (PNS Diseases) 01/2008
1	Dizziness (Lightheadedness) 01/2008
1	Neutropenia 01/2008
1	Exanthema (Rash) 01/2008
1	Bacterial Pneumonia 10/2007
1	Bacterial Infections (Bacterial Infection) 10/2007
1	Pneumonia (Pneumonitis) 10/2007
1	Salmonella Infections (Salmonellosis) 10/2007
1	Silicosis 06/2005

Drug/Important Bio-Agent (IBA)

38	Isoniazid (Ftivazide)FDA LinkGeneric 12/2021 - 12/2002
25	Pharmaceutical PreparationsIBA 09/2022 - 03/2002
19	rifapentine (Priftin)FDA Link 09/2022 - 04/2006
15	Rifampin (Rifampicin)FDA LinkGeneric 01/2021 - 07/2002
11	Tuberculin (PPD)IBA 12/2021 - 06/2002
10	Moxifloxacin (Avelox)FDA Link 09/2022 - 02/2004
9	Pyrazinamide FDA LinkGeneric 01/2021 - 07/2002
7	efavirenz (Sustiva)FDA Link 09/2022 - 01/2002
7	RNA (Ribonucleic Acid)IBA 11/2011 - 03/2002
5	Ethambutol (Myambutol)FDA LinkGeneric 01/2021 - 08/2006
4	Biomarkers (Surrogate Marker)IBA 01/2021 - 10/2016
4	RifamycinsIBA 01/2020 - 10/2003
4	GoldIBA 01/2014 - 09/2003
3	9 alpha,11 alpha,15 alpha- trihydroxy- 16- phenoxy- 17,18,19,20- tetranorprosta- 4,5,13- trienoic acid (TPT)IBA 02/2021 - 10/2020
3	Sulfamethoxazole Drug Combination Trimethoprim (Co-Trimoxazole)FDA LinkGeneric 01/2014 - 07/2010
3	lipoarabinomannan (LAM)IBA 10/2011 - 10/2009
3	EnzymesIBA 10/2011 - 11/2004
3	Protease Inhibitors (Protease Inhibitor)IBA 11/2004 - 01/2002
3	Heroin (Diamorphine)IBA 05/2004 - 03/2002
2	VaccinesIBA 01/2022 - 11/2019
2	Dihydrotachysterol (AT 10)IBA 01/2022 - 05/2011
2	Clofazimine (Lamprene)FDA Link 01/2019 - 01/2018
2	Hepatitis B Surface Antigens (HBsAg)FDA Link 01/2014 - 06/2007
2	DNA (Deoxyribonucleic Acid)IBA 01/2014 - 10/2007
2	AntibodiesIBA 01/2014 - 06/2002
2	Reverse Transcriptase InhibitorsIBA 12/2009 - 08/2003
2	insulin receptor-related receptor (IRR)IBA 03/2009 - 06/2005
2	Nevirapine (Viramune)FDA Link 10/2008 - 01/2002
1	C-Reactive ProteinIBA 01/2022
1	ChAdOx1 nCoV-19IBA 01/2022
1	HLA Antigens (Human Leukocyte Antigens)IBA 01/2021
1	CreatinineIBA 01/2020
1	dolutegravirIBA 01/2020
1	FluoroquinolonesIBA 02/2016
1	Antitubercular AgentsIBA 01/2016
1	Surface Antigens (Surface Antigen)IBA 01/2014
1	Immunoglobulins (Immunoglobulin)IBA 01/2014
1	Antiviral Agents (Antivirals)IBA 01/2014
1	InterferonsIBA 07/2012
1	golimumab FDA Link 07/2012
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 07/2012
1	AcidsIBA 10/2011
1	ImmunosorbentsIBA 10/2011
1	Anti-Retroviral Agents (Antiretroviral Agents)IBA 04/2011
1	2- cyclohexylidenhydrazo- 4- phenyl- thiazoleIBA 07/2010
1	NucleosidesIBA 12/2009
1	Anti-Bacterial Agents (Antibiotics)IBA 10/2007
1	Illicit Drugs (Recreational Drugs)IBA 03/2006

Therapy/Procedure

57	Therapeutics 12/2021 - 01/2002
19	Highly Active Antiretroviral Therapy (HAART) 09/2014 - 04/2002
9	Art Therapy 01/2018 - 11/2004
3	Duration of Therapy 01/2020 - 02/2004
3	Drug Therapy (Chemotherapy) 01/2016 - 06/2003
2	Immunotherapy 12/2014 - 09/2014
1	Ambulatory Care (Outpatient Care) 11/2008